Cancer biomarkers: the role of structured data reporting.
Arch Pathol Lab Med
; 139(5): 587-93, 2015 May.
Article
em En
| MEDLINE
| ID: mdl-25275812
CONTEXT: The College of American Pathologists has been producing cancer protocols since 1986 to aid pathologists in the diagnosis and reporting of cancer cases. Many pathologists use the included cancer case summaries as templates for dictation/data entry into the final pathology report. These summaries are now available in a computer-readable format with structured data elements for interoperability, packaged as "electronic cancer checklists." Most major vendors of anatomic pathology reporting software support this model. OBJECTIVES: To outline the development and advantages of structured electronic cancer reporting using the electronic cancer checklist model, and to describe its extension to cancer biomarkers and other aspects of cancer reporting. DATA SOURCES: Peer-reviewed literature and internal records of the College of American Pathologists. CONCLUSIONS: Accurate and usable cancer biomarker data reporting will increasingly depend on initial capture of this information as structured data. This process will support the standardization of data elements and biomarker terminology, enabling the meaningful use of these datasets by pathologists, clinicians, tumor registries, and patients.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Patologia Clínica
/
Biomarcadores Tumorais
/
Registros Eletrônicos de Saúde
/
Neoplasias
Tipo de estudo:
Guideline
/
Prognostic_studies
/
Qualitative_research
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Arch Pathol Lab Med
Ano de publicação:
2015
Tipo de documento:
Article